ACQUIRED · 2024
Who Acquired OPKO / BioReference Clinical Diagnostics Business?
Labcorp · $237.6M · 2024
The acquisition
OPKO / BioReference Clinical Diagnostics Business was acquired by Labcorp in 2024 for $237.6M.
OPKO / BioReference Clinical Diagnostics Business at time of acquisition
Revenue
$100.0M
Deal value
$237.6M
Own a laboratory services business? See what it's worth.
Labcorp acquired OPKO / BioReference Clinical Diagnostics Business for $237.6M. Get an M&A-grade EBITDA range and sellability score for your own business, benchmarked against 25,592 real transactions. 2 minutes, no signup.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Other acquisitions by Labcorp
Recent transactions by the same buyer — context on their deal flow and footprint.
- OPKO / BioReference Health (Clinical Diagnostics Business) · 2025 · $192.5M
Similar laboratory services acquisitions
- GeneSeek (Neogen Animal Genomics) · acquired by Zoetis in 2026 · $160.0M
- CHS Outreach Laboratory Assets · acquired by Laboratory Corporation of America Holdings in 2025 · $194.5M
- OPKO / BioReference Health (Clinical Diagnostics Business) · acquired by Labcorp in 2025 · $192.5M
- Akoya Biosciences, Inc. · acquired by Quanterix Corporation in 2025 · $286.0M
- Enzo Biochem, Inc. · acquired by Battery Ventures in 2025 · $37.0M
More on laboratory services valuations
- Value a laboratory services· run the calculator
- Laboratory Services median multiples· real-deal benchmarks
- Who buys laboratory services businesses?· active buyers
- Who acquired GeneSeek (Neogen Animal Genomics)?· buyer profile
- How to value a laboratory services· long-form guide
Sourced from SEC filings and press releases. Full deal page
Citation: ExitValue.ai. (2024). OPKO / BioReference Clinical Diagnostics Business acquired by Labcorp. https://exitvalue.ai/acquired/opko-bioreference-clinical-diagnostics-business